Therapeutic method for the treatment or prevention of snoring
US5516765A · kind A · utility
9Cited by
1References
10Claims
0Family size
Inventor
Key dates
| Filing date | Dec 19, 1994 |
| Grant date | May 14, 1996 |
| Priority date | — |
| Expiry date | Dec 19, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K36/81
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This new solution according to the invention, contains mucopolysaccharides of the glycosaminoglycane type as principle active agent, and more precisely sodic chondroitin sulphate. The excipient of this composition contains at least one mercury preserving agent, one substance with isotonic properties, and a phosphate buffer. The principle active agent may be combined with plant or mineral compounds, or with homeopathic or allopathic concentrations which synergise its therapeutic activities.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.